Cargando…

de novo Blood Biomarkers in Autism: Autoantibodies against Neuronal and Glial Proteins

Autism spectrum disorders (ASDs) are the most common neurodevelopmental disorders with unidentified etiology. The behavioral manifestations of ASD may be a consequence of genetic and/or environmental pathology in neurodevelopmental processes. In this limited study, we assayed autoantibodies to a pan...

Descripción completa

Detalles Bibliográficos
Autores principales: Abou-Donia, Mohamed B., Suliman, Hagir B., Siniscalco, Dario, Antonucci, Nicola, ElKafrawy, Passent, Brahmajothi, Mulugu V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6563083/
https://www.ncbi.nlm.nih.gov/pubmed/31035713
http://dx.doi.org/10.3390/bs9050047
_version_ 1783426470146736128
author Abou-Donia, Mohamed B.
Suliman, Hagir B.
Siniscalco, Dario
Antonucci, Nicola
ElKafrawy, Passent
Brahmajothi, Mulugu V.
author_facet Abou-Donia, Mohamed B.
Suliman, Hagir B.
Siniscalco, Dario
Antonucci, Nicola
ElKafrawy, Passent
Brahmajothi, Mulugu V.
author_sort Abou-Donia, Mohamed B.
collection PubMed
description Autism spectrum disorders (ASDs) are the most common neurodevelopmental disorders with unidentified etiology. The behavioral manifestations of ASD may be a consequence of genetic and/or environmental pathology in neurodevelopmental processes. In this limited study, we assayed autoantibodies to a panel of vital neuronal and glial proteins in the sera of 40 subjects (10 children with ASD and their mothers along with 10 healthy controls, age-matched children and their mothers). Serum samples were screened using Western Blot analysis to measure immunoglobulin (IgG) reactivity against a panel of 9 neuronal proteins commonly associated with neuronal degeneration: neurofilament triplet proteins (NFP), tubulin, microtubule-associated proteins (tau), microtubule-associated protein-2 (MAP-2), myelin basic protein (MBP), myelin-associated glycoprotein (MAG), α-synuclein (SNCA) and astrocytes proteins such as glial fibrillary acidic protein (GFAP) and S100B protein. Our data show that the levels of circulating IgG class autoantibodies against the nine proteins were significantly elevated in ASD children. Mothers of ASD children exhibited increased levels of autoantibodies against all panel of tested proteins except for S100B and tubulin compared to age-matched healthy control children and their mothers. Control children and their mothers showed low and insignificant levels of autoantibodies to neuronal and glial proteins. These results strongly support the importance of anti-neuronal and glial protein autoantibodies biomarker in screening for ASD children and further confirm the importance of the involvement of the maternal immune system as an index that should be considered in fetal in utero environmental exposures. More studies are needed using larger cohort to verify these results and understand the importance of the presence of such autoantibodies in children with autism and their mothers, both as biomarkers and their role in the mechanism of action of autism and perhaps in its treatment.
format Online
Article
Text
id pubmed-6563083
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-65630832019-06-17 de novo Blood Biomarkers in Autism: Autoantibodies against Neuronal and Glial Proteins Abou-Donia, Mohamed B. Suliman, Hagir B. Siniscalco, Dario Antonucci, Nicola ElKafrawy, Passent Brahmajothi, Mulugu V. Behav Sci (Basel) Article Autism spectrum disorders (ASDs) are the most common neurodevelopmental disorders with unidentified etiology. The behavioral manifestations of ASD may be a consequence of genetic and/or environmental pathology in neurodevelopmental processes. In this limited study, we assayed autoantibodies to a panel of vital neuronal and glial proteins in the sera of 40 subjects (10 children with ASD and their mothers along with 10 healthy controls, age-matched children and their mothers). Serum samples were screened using Western Blot analysis to measure immunoglobulin (IgG) reactivity against a panel of 9 neuronal proteins commonly associated with neuronal degeneration: neurofilament triplet proteins (NFP), tubulin, microtubule-associated proteins (tau), microtubule-associated protein-2 (MAP-2), myelin basic protein (MBP), myelin-associated glycoprotein (MAG), α-synuclein (SNCA) and astrocytes proteins such as glial fibrillary acidic protein (GFAP) and S100B protein. Our data show that the levels of circulating IgG class autoantibodies against the nine proteins were significantly elevated in ASD children. Mothers of ASD children exhibited increased levels of autoantibodies against all panel of tested proteins except for S100B and tubulin compared to age-matched healthy control children and their mothers. Control children and their mothers showed low and insignificant levels of autoantibodies to neuronal and glial proteins. These results strongly support the importance of anti-neuronal and glial protein autoantibodies biomarker in screening for ASD children and further confirm the importance of the involvement of the maternal immune system as an index that should be considered in fetal in utero environmental exposures. More studies are needed using larger cohort to verify these results and understand the importance of the presence of such autoantibodies in children with autism and their mothers, both as biomarkers and their role in the mechanism of action of autism and perhaps in its treatment. MDPI 2019-04-29 /pmc/articles/PMC6563083/ /pubmed/31035713 http://dx.doi.org/10.3390/bs9050047 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Abou-Donia, Mohamed B.
Suliman, Hagir B.
Siniscalco, Dario
Antonucci, Nicola
ElKafrawy, Passent
Brahmajothi, Mulugu V.
de novo Blood Biomarkers in Autism: Autoantibodies against Neuronal and Glial Proteins
title de novo Blood Biomarkers in Autism: Autoantibodies against Neuronal and Glial Proteins
title_full de novo Blood Biomarkers in Autism: Autoantibodies against Neuronal and Glial Proteins
title_fullStr de novo Blood Biomarkers in Autism: Autoantibodies against Neuronal and Glial Proteins
title_full_unstemmed de novo Blood Biomarkers in Autism: Autoantibodies against Neuronal and Glial Proteins
title_short de novo Blood Biomarkers in Autism: Autoantibodies against Neuronal and Glial Proteins
title_sort de novo blood biomarkers in autism: autoantibodies against neuronal and glial proteins
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6563083/
https://www.ncbi.nlm.nih.gov/pubmed/31035713
http://dx.doi.org/10.3390/bs9050047
work_keys_str_mv AT aboudoniamohamedb denovobloodbiomarkersinautismautoantibodiesagainstneuronalandglialproteins
AT sulimanhagirb denovobloodbiomarkersinautismautoantibodiesagainstneuronalandglialproteins
AT siniscalcodario denovobloodbiomarkersinautismautoantibodiesagainstneuronalandglialproteins
AT antonuccinicola denovobloodbiomarkersinautismautoantibodiesagainstneuronalandglialproteins
AT elkafrawypassent denovobloodbiomarkersinautismautoantibodiesagainstneuronalandglialproteins
AT brahmajothimuluguv denovobloodbiomarkersinautismautoantibodiesagainstneuronalandglialproteins